← Back to Search

Behavioral Intervention

DBT Skills Training + Safety Planning for Suicide Risk

N/A

Recruiting

Led By Stephanie D Step, PhD

Research Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Biological mothers with legal custody of target child between 9-11

Must not have

Cardiac nervous system abnormalities that would influence physiological readings

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, all follow-up time points (3, 6, 12, and 24 months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to understand how a mother's emotions can impact the risk of suicide in her children. Participants will undergo assessments and follow-ups for a year. The study is a randomized controlled trial where participants

Who is the study for?

This trial is for biological mothers with legal custody of a child aged 9-11, who have a history of suicidal behavior. It's not suitable for those with cardiac or nervous system abnormalities, recent DBT therapy, or major medical illnesses like Parkinson's Disease that affect personality or emotion regulation.

What is being tested?

The study compares Dialectical Behavior Therapy (DBT) Skills Training against treatment as usual for reducing suicide risk. Mothers are randomly assigned to either attend weekly DBT sessions for six months or receive the standard care.

What are the potential side effects?

While specific side effects are not listed, DBT generally involves discussing and managing emotional distress which can sometimes be uncomfortable but is part of the therapeutic process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am the biological mother with legal custody of a child aged 9-11.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have heart or nervous system conditions that could affect heart rate or blood pressure measurements.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, all follow-up time points (3, 6, 12, and 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, all follow-up time points (3, 6, 12, and 24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, all follow-up time points (3, 6, 12, and 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Child Suicidal Thoughts and Behaviors

Secondary study objectives

Child Mental Health Outcomes

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Safety Planning InterventionExperimental Treatment1 Intervention

Safety Planning Intervention (SPI) or SPI only for 6 months, such that all mothers with history of suicidal behavior + ER difficulties will receive SPI.

Group II: Dialectical Behavior Therapy Skills Group TrainingExperimental Treatment1 Intervention

The investigators will employ Dialectical Behavior Therapy Skills Training in order to experimentally manipulate maternal emotion dysregulation, our targeted mechanism.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Safety Planning Intervention

2017

N/A

~500

0 / 2Eligibility criteria met